dactinomycin has been researched along with Gram-Positive Bacterial Infections in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, KJ; Lei, HY; Lin, YS; Wang, SD | 1 |
Morisawa, Y; Sasahara, T; Suzuki, J; Toshima, M | 1 |
Akiyama, K; Hiramatsu, N; Igari, J; Koyama, T; Oguri, T | 1 |
Okonogi, K; Tsuchimori, N; Yamazaki, T | 1 |
1 review(s) available for dactinomycin and Gram-Positive Bacterial Infections
Article | Year |
---|---|
Peripherally inserted central catheter-related bloodstream infection due to Tsukamurella pulmonis: a case report and literature review.
Topics: Acquired Immunodeficiency Syndrome; Actinobacteria; Administration, Intravenous; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Catheter-Related Infections; Catheterization, Peripheral; Cefozopran; Cephalosporins; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged | 2017 |
3 other study(ies) available for dactinomycin and Gram-Positive Bacterial Infections
Article | Year |
---|---|
Sepsis-induced apoptosis of the thymocytes in mice.
Topics: Animals; Apoptosis; Atrophy; Cycloheximide; Dactinomycin; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Mice; Mice, Inbred C3H; T-Lymphocytes; Thymus Gland; Tumor Necrosis Factor-alpha | 1994 |
[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
Topics: Carbapenems; Cefozopran; Cephalosporins; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Penicillins; Product Surveillance, Postmarketing; Time Factors | 2003 |
Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice.
Topics: Ampicillin; Animals; Cefozopran; Ceftazidime; Cephalosporins; Cilastatin; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Imipenem; Mice; Mice, Inbred CBA; Ofloxacin; Pseudomonas Infections; Urinary Tract Infections | 1997 |